Abeona Therapeutics Inc.

ABEO · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$64-$54-$40-$85
Dep. & Amort.$3$3$5$4
Deferred Tax$0$0$0$0
Stock-Based Comp.$7$5$3$9
Change in WC-$4-$2-$6-$18
Other Non-Cash$3$11-$6$24
Operating Cash Flow-$56-$37-$43-$66
Investing Activities
PP&E Inv.-$2-$0-$0-$4
Net Acquisitions$0$0$0$0
Inv. Purchases-$157-$52-$78-$20
Inv. Sales/Matur.$120$52$53$90
Other Inv. Act.$0$0$2$0
Investing Cash Flow-$39$0-$24$66
Financing Activities
Debt Repay.$20$0$0$0
Stock Issued$86$37$47$24
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$1-$0-$4$1
Financing Cash Flow$104$37$43$25
Forex Effect$0$0$0$0
Net Chg. in Cash$9$0-$24$25
Supplemental Information
Beg. Cash$15$15$39$14
End Cash$24$15$15$39
Free Cash Flow-$58-$37-$44-$70
Abeona Therapeutics Inc. (ABEO) Financial Statements & Key Stats | AlphaPilot